Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Anti-IL5 Therapy on Sputum Cells and Cytokines
NCT04412044Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Sep 2016
- Primary completion
- May 2018
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of mepolizumab in asthma, sponsored by KU Leuven. Started Sep 2016; status: completed.
02
Drugs
mepolizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04412044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04412044.